Skip to Content

Search Results

Results for: ""

Show:

Webcast: TD Cowen 46th Annual Health Care Conference

Crinetics Management will participate in a fireside chat on Wednesday, March 4, 2026 at 1:50 p.m. Eastern Time. Live &...

READ MORE

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March

Crinetics announced that company management will participate in two upcoming investor conferences: the TD Cowen 46th Annual Health Care Conference...

READ MORE

Crinetics Pharmaceuticals, Inc. Corporate Update

Event Date: January 5, 2026

READ MORE

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Crinetics announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after...

READ MORE

Webcast: Crinetics to Report Fourth Quarter and Full Year 2025 Financial Results

Crinetics Pharmaceuticals will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market...

READ MORE

Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Crinetics announced that the first patient has been dosed in the BALANCE-CAH Phase 2/3 trial evaluating investigational candidate atumelnant, a...

READ MORE

Webcast: Crinetics Pharmaceuticals Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will present at the 44th Annual J.P. Morgan Healthcare Conference being...

READ MORE

Crinetics Pharmaceuticals Announces January 2026 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals, Inc. today announced that on January 10, 2026, the Compensation Committee of the Board of Directors granted non-qualified...

READ MORE